All In Biotech

Drug Trial Radar · NCT06720896

A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.

Vision and Inflammation Study Testing Anti-acarid Therapeutics (VISTA-1): A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.

Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

66

Actual

Start

Nov 1, 2025

Primary completion

Jul 13, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Aperta Biosciences, LLCIndustry
Sponsor type
Industry
First posted
Dec 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish the clinical efficacy of APT-001 topical therapy 1.8% in patients with blepharitis as compared to its vehicle control, and to establish that the therapeutic is safe and generally well tolerated by patients.

Conditions

  • Blepharitis

Interventions

  • APT-001 topical ophthalmic ointment (spinosad)Drug

    APT-001 topical ophthalmic ointment, administered once daily

  • Vehicle control for APT-001 topical ophthalmic ointmentDrug

    Vehicle control for APT-001 topical ophthalmic ointment, administered once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Collarette CureTime frame: From enrollment to the end of treatment at 6 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Dr. Rudy Gutierrez Diaz Sede Central

    Guatemala City, Guatemala

  • EyeScan, Imágenes Diagnósticas Oculares, S. A.

    Guatemala City, Guatemala

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.